Human Health and Potential (HHP)

Scientists create a platform for reliably customising antibody molecular structures, opening the door to more potent and effective antibody medicines.

Researchers discover that the deletion of a gene linked to glucose metabolism leads to smaller pancreatic tumours and better patient survival.

A*STAR researchers blend the physics of particle dynamics with complex computational simulations to gauge the risk of catching COVID-19 in different social settings.

Synthetic DNA molecules could serve as an easy-to-manufacture alternative to traditional antibody-based rapid tests.

Experimental gene therapy promises a new lease of life for patients with genetic heart disease.

New gastric cancer insights come to light with the help of powerful single-cell technologies.

A*STAR researchers develop a standardised, self-administered taste and smell test for detecting the early symptoms of COVID-19.

A molecular tagging tool developed in Singapore identifies novel protein interactions on the surface of cancer cells.

A breakthrough discovery describes key molecular players involved in insulin secretion, paving the way for a new class of gene therapies targeting type 2 diabetes.

Cancer genetics experts say new technologies and more comprehensive data collection are required to deepen our understanding of tumour lifecycles.

By looking at Peranakan Chinese genomes, researchers confirm the community arose from genetic mixing between local Malay women and foreign Chinese traders in the past.

Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.